Latest News


Carrick Wins Prestigious Life Sciences Finance Award

Carrick Therapeutics is delighted to have been successful at this year’s Biotech and Money Awards Gala in London. The Awards recognised success and achievement over the past year in the biotech sector in the UK and Ireland. Carrick won the award for the “Private...

Carrick Therapeutics appoints chairman as one of two new board members

Board bolstered by the addition of Dr Burt Adelman as chair and Dr Clive Dix as non-executive director ahead of further significant announcements Carrick Therapeutics - established in October 2016 with $95 million of initial funding, with the aim of building Europe’s...

Carrick Therapeutics in the media

New Class Of Drugs Could Help Tackle Treatment-Resistant Cancers

Apr 23, 2018

Read more

Elaine Sullivan shortlisted for EOY Entrepreneur of the Year 2018 Award

Apr 23, 2018

Read more

Innovators Magazine: Drug fights therapy-resistant cancers

Apr 10, 2018

Read more

News Medical: New class of drug holds potential to help patients with treatment-resistant cancers

Apr 10, 2018

Read more

Creating a premier oncology company in Europe – BioPharma Dealmakers / Nature magazine

March, 2018

Read more

Emory Tech Transfer Annual Celebration Winners 2017

Feb 28, 2017

Carrick wins “Deal of 2016”. Read more Interviews Top Women in Biotech

Nov 7, 2017

Say Hello to the Top Female Entrepreneurs in European Biotech. Read more

Biotech and Money: Winner’s Spotlight – Carrick Therapeutics

Nov 3, 2017

An interview with Elaine Sullivan Co-Founder & CEO Carrick Therapeutics. Read more

WuXi AppTec Press: Solid as a Rock: Creating a Strong Foundation for Developing First-in-Class Treatments to Fight Aggressive Cancers

May 10, 2017

An interview with Elaine Sullivan, Co-Founder & CEO, Carrick Therapeutics. Read more

Financial Times: Investors seek to build European oncology start-up

Oct 3, 2016

Leading cancer specialists in the UK and Ireland are aiming to build Europe’s leading oncology company backed by venture capitalists from the US and Europe. Read more

FierceBiotech: Oncology fledgling Carrick bags $95M Series A, names ex-AstraZeneca, Lilly exec as CEO

Oct 3, 2016

Carrick Therapeutics has wrapped up a $95 million (€85 million) Series A to fuel its ambition to grow into Europe’s leading oncology company. Read more

The Irish Times: Irish oncology start-up attracts $95m funding

Oct 3, 2016

A new Irish company treatment company, Carrick Therapeutics, has attracted $95 million (€84.5 million) in an initial funding round. Read more

Wall Street Journal: Cancer Drug Developer Carrick Therapeutics Launches With $95M

Oct 3, 2016

Carrick Therapeutics Ltd. is launching with $95 million from U.S. and European investors to develop therapies that disrupt molecular processes driving aggressive and drug-resistant cancers. Read more

Endpoints: $95M mega-round in hand, Elaine Sullivan sets out to build a European oncology player

Oct 3, 2016

A trans-Atlantic investment syndicate that includes Google has come together to bankroll a European oncology startup with a $95 million mega-round. Read more

Biospace: New Startup Carrick Therapeutics Launches With $95 Million and Taps Former AstraZeneca PLC (AZN)-Eli Lilly (LLY) Exec as CEO

Oct 3, 2016

Dublin-based Carrick Therapeutics blasts out of the gate, launching with $95 million in funding. Read more

Irish Business Insider: $95M funding for pioneering cancer researcher

Oct 3, 2016

A new venture which hopes to pioneer treatments for aggressive and resistant forms of cancer has been launched after securing funding worth $95m (£74m/€84.6m). Read more